Robert Langer

Founder at Alnylam Pharmaceuticals, Inc.

Robert Langer

Robert Langer

Founder at Alnylam Pharmaceuticals, Inc.

Overview
Career Highlights

Seer, Inc. (California)
Sigilon Therapeutics, Inc.
Lyndra Therapeutics, Inc.

RelSci Relationships

6916

Primary Location

United States

Number of Boards

82

Birthday

1948 - Albany, NY

Age

73

Number of Awards

27

Contact Data
Trying to get in touch with Robert Langer? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Robert Langer likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Lyndra Therapeutics, Inc.

Relationship likelihood: Strong

Founding Partner at Polaris Partners

Relationship likelihood: Strong

Partner at Polaris Partners

Relationship likelihood: Strong

Co-Founder at Pandion Operations, Inc.

Relationship likelihood: Strong

Professor at Harvard University

Relationship likelihood: Strong

Co-Founder at Moderna, Inc.

Relationship likelihood: Strong

Managing Partner at Flagship Pioneering

Relationship likelihood: Strong

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Faculty Director, Lemelson-MIT Program at Massachusetts Institute of Technology

Relationship likelihood: Strong

Paths to Robert Langer
Potential Connections via
Relationship Science
You
Robert Langer
Founder at Alnylam Pharmaceuticals, Inc.
Family Members
Education
SC.D. Chemical Engineering
Class of 1974

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Bachelor's Degree in Chemical Engineering
Class of 1970

Cornell is a privately endowed research university and a partner of the State University of New York. As the federal land-grant institution in New York State, they have a responsibility—unique within the Ivy League—to make contributions in all fields of knowledge in a manner that prioritizes public engagement to help improve the quality of life in our state, the nation, the world.

Memberships
Member
1989 - Prior

The National Academy of Medicine (NAM), formerly called the Institute of Medicine (IoM), is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC). The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health. It aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.

Member
Prior

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Member
Prior

Founded in 1964, the National Academy of Engineering (NAE) is a private, independent, nonprofit institution that provides engineering leadership in service to the nation. The mission of the National Academy of Engineering is to advance the well-being of the nation by promoting a vibrant engineering profession and by marshalling the expertise and insights of eminent engineers to provide independent advice to the federal government on matters involving engineering and technology.

Career History
Co-Founder
2017 - Current

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr., and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.

Director
2017 - Current

Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA.

Co-Founder
2015 - Current

Sigilon Therapeutics, Inc. engages in the research and development of therapeutic treatments for a wide range of chronic diseases. The company was founded by Daniel G. Anderson, Robert S. Langer Jr., Jose Oberholzer, Arturo Vegas, and Omid Veiseh on May 14, 2015 and is headquartered in Cambridge, MA.

Boards & Committees
Member, Scientific Advisory Board
Current

FirstString Research, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC.

Member, Scientific & Clinical Advisory Board
Current

Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France.

Director
2009 - 2010

EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA.

Trustee
Tenure Unconfirmed
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $999
2006

Whitehead Institute is a world-renowned non-profit research institution dedicated to improving human health through basic biomedical research. By cultivating a deeply collaborative culture and enabling the pursuit of bold, creative inquiry, Whitehead fosters paradigm-shifting scientific achievement. For more than 30 years, Whitehead faculty have delivered breakthroughs that have transformed our understanding of biology and accelerated development of therapies for such diseases as Alzheimer’s, Parkinson’s, diabetes, and certain cancers. Located in Cambridge, Massachusetts, Whitehead Institute was founded in 1982 by businessman and philanthropist Edwin C. “Jack” Whitehead.

Transactions
Details Hidden

Verseau Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Tarveda Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA.

Details Hidden

Suono Bio, Inc. develops therapeutics to the gastrointestinal tract which helps to cure diseases. The company was founded by Carl Schoellhammer, Robert S. Langer Jr., Amy W. Schulman, and Giovanni Traverso and is headquartered in Cambridge, MA.

Details Hidden

Sigilon Therapeutics, Inc. engages in the research and development of therapeutic treatments for a wide range of chronic diseases. The company was founded by Daniel G. Anderson, Robert S. Langer Jr., Jose Oberholzer, Arturo Vegas, and Omid Veiseh on May 14, 2015 and is headquartered in Cambridge, MA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2014
Biotechnology Heritage Award
2011
National Medal of Technology and Innovation
2006
National Medal of Science
Events
Speaker
Aspen, CO, United States
2010 Aspen Ideas Festival

Aspen Ideas Festival, presented by the Aspen Institute and The Atlantic, continues to broaden its reach and engage with more people than ever before on ideas that matter. A major focus throughout the Festival, which opens today, is increasing live and on-demand video opportunities for online viewers around the world.

Other Affiliations

Robert Langer is affiliated with Seer, Inc. (California), Verseau Therapeutics, Inc., Sigilon Therapeutics, Inc., Lyndra Therapeutics, Inc., Suono Bio, Inc., Frequency Therapeutics, Inc., Tarveda Therapeutics, Inc., Modernatx, Inc., TARIS BioMedical LLC, Selecta Biosciences, Inc., Pulmatrix, Inc. (Inactive), Alnylam Pharmaceuticals, Inc., Puretech Health LLC, The David H. Koch Institute for Integrative Cancer Research, Seventh Sense Biosystems, Inc., Living Proof, Inc., Entrega Bio, 3-D Matrix, Inc., Massachusetts Institute of Technology - School of Engineering, Massachusetts Institute of Technology - Institute for Medical Engineering & Science, Moderna, Inc., Eagle Biologics, Inc., T2 Biosystems, Inc., Acusphere, Inc., Advanced Inhalation Research, Inc., Olivo Laboratories LLC, XTuit Pharmaceuticals, Inc., Pulmatrix, Inc., PureTech Health PLC, SQZ Biotechnologies Company, Tissium SA, Kala Pharmaceuticals, Inc., Semprus BioSciences Corp., Lyra Therapeutics, Inc., DNIB Unwind, Inc., Invivo Therapeutics Holdings Corp., InVivo Therapeutics Corp., Momenta Pharmaceuticals, Inc., Combinent BioMedical Systems, Inc., Microchips Biotech, Inc., TransForm Pharmaceuticals, Inc., U.S. Food and Drug Administration, Echo Therapeutics Inc., The Children's Hospital Corp., Harvard University - Harvard Medical School, PixarBio Corporation, Sontra Medical, Inc., Massachusetts Institute of Technology - Whitaker College of Health Sciences and Technology, Sienna Labs, Inc., Polaris Partners, The Water Initiative LLC, FirstString Research, Inc., Tissium SA, EMD Millipore Corporation, Alseres Pharmaceuticals, Inc., Sontra Medical Corp., Galenus Foundation

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert Langer. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert Langer's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert Langer.